Login to Your Account

Taking big step in ADCs, South Korea's Legochem partners with Takeda

By Haky Moon
Staff Writer

Friday, January 20, 2017

HONG KONG – Small South Korean biopharma firm Legochem Biosciences Inc. is looking to turbo-charge its operations by partnering with Takeda Pharmaceuticals Co. Ltd., one of just two companies that has successfully commercialized an antibody-drug conjugate (ADC) drug.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription